These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

49 related items for PubMed ID: 2987712

  • 1. The in situ immunological reactivity and its significance in the clinical behavior of the cervical human papillomavirus lesions.
    Syrjänen K, Väyrynen M, Hippeläinen M, Castrén O, Saarikoski S, Mäntyjärvi R.
    Neoplasma; 1985; 32(2):181-90. PubMed ID: 2987712
    [Abstract] [Full Text] [Related]

  • 2. Factors influencing the biological behaviour of cervical human papillomavirus (HPV) infections in prospectively followed-up women.
    Syrjänen K, Mäntyjärvi R, Väyrynen M, Holopainen H, Saarikoski S, Castrén O.
    Arch Geschwulstforsch; 1985; 55(6):457-66. PubMed ID: 3002294
    [Abstract] [Full Text] [Related]

  • 3. Electron microscopy in assessment of the biological behavior of human papillomavirus infections in the uterine cervix.
    Syrjänen K, Väyrynen M, Mäntyjärvi R, Holopainen H, Saarikoski S, Syrjänen S, Parkkinen S, Castrén O.
    Neoplasma; 1986; 33(4):493-505. PubMed ID: 3020455
    [Abstract] [Full Text] [Related]

  • 4. Cervical smears in assessment of the natural history of human papillomavirus infections in prospectively followed women.
    Syrjänen KJ, Mäntyjärvi R, Väyrynen M, Yliskoski M, Syrjänen SM, Saarikoski S, Nurmi T, Parkkinen S, Castrén O.
    Acta Cytol; 1987; 31(6):855-65. PubMed ID: 2827414
    [Abstract] [Full Text] [Related]

  • 5. Electron microscopic assessment of cervical punch biopsies in women followed-up for human papillomavirus (HPV) lesions.
    Syrjänen K, Väyrynen M, Hippeläinen M, Castrén O, Saarikoski S, Mäntyjärvi R.
    Arch Geschwulstforsch; 1985; 55(2):131-8. PubMed ID: 2988479
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Local immunological reactivity in oral squamous cell lesions of possible HPV (human papillomavirus) origin.
    Syrjänen KJ, Syrjänen SM, Lamberg MA, Happonen RP.
    Arch Geschwulstforsch; 1983; 53(6):537-46. PubMed ID: 6322720
    [Abstract] [Full Text] [Related]

  • 10. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A, Schiffman MH, Tsukui T, Swanson CA, Lucci J, Scott DR, Glass AG, Rush BB, Lorincz AT, Corrigan A, Burk RD, Helgesen K, Houghten RA, Sherman ME, Kurman RJ, Berzofsky JA, Kramer TR.
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A, Schiffman M, Scott DR, Marti D, Kissner T, Sherman ME, Glass AG, Manos MM, Lorincz AT, Kurman RJ, Buckland J, Rush BB, Carrington M.
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human papillomavirus (HPV) infections involved in the neoplastic process of the uterine cervix as established by prospective follow-up of 513 women for two years.
    Syrjänen K, Mäntyjärvi R, Väyrynen M, Syrjänen S, Parkkinen S, Yliskoski M, Saarikoski S, Castrén O.
    Eur J Gynaecol Oncol; 1987 Nov; 8(1):5-16. PubMed ID: 3032634
    [Abstract] [Full Text] [Related]

  • 17. Human papillomavirus infection and cervical neoplasia: new perspectives.
    Crum CP, Levine RU.
    Int J Gynecol Pathol; 1984 Nov; 3(4):376-88. PubMed ID: 6096281
    [Abstract] [Full Text] [Related]

  • 18. Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer.
    Branca M, Ciotti M, Santini D, Bonito LD, Benedetto A, Giorgi C, Paba P, Favalli C, Costa S, Agarossi A, Alderisio M, Syrjänen K, HPV-Pathogen ISS Study Group.
    Am J Clin Pathol; 2004 Dec; 122(6):902-11. PubMed ID: 15539382
    [Abstract] [Full Text] [Related]

  • 19. [Correlations between the HPV type, DNA index and evolution of cervical intraepithelial neoplasia (CIN)].
    Sassi I, Mangili F, Luchini S, Colombo G, Pezzotta MG, Candiani M, Frigerio A, Santambrogio G, Cantaboni A, Vignali M.
    Pathologica; 1993 Dec; 85(1095):79-84. PubMed ID: 8390639
    [Abstract] [Full Text] [Related]

  • 20. Natural killer (NK) cells with HNK-1 phenotype in the cervical biopsies of women followed-up for human papillomavirus (HPV) lesions.
    Syrjänen K, Väyrynen M, Mäntyjärvi R, Castren O, Saarikoski S.
    Acta Obstet Gynecol Scand; 1986 Dec; 65(2):139-45. PubMed ID: 3014803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.